xelox
Small moleculeexperimental
Clinical trial activity
14 trials · 18 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
14
Phase 3
5
Phase 4
0
Earliest trial started Aug 23, 2017 (NCT03322969)
Timeline
Indications
Studied for
- alpha-Fetoproteins · Phase 2
- Colonic Neoplasms · Phase 3
- Colorectal Neoplasms · Phase 3
- DNA Mismatch Repair · Phase 2
- Drug Therapy · Phase 2
- Esophageal Neoplasms · Phase 2
- General Surgery · Phase 3
- Immune Checkpoint Inhibitors · Phase 2
- Neoplasms · Phase 1/Phase 2
- Radiation · Phase 2
- Radiotherapy · Phase 2
- Rectal Neoplasms · Phase 3
- Stomach Neoplasms · Phase 3
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- xelox
- xelox protocol
- xelox rt
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05074966 | Phase 3 | Sep 6, 2021 | Chinese Academy of Medical Sciences |
| NCT04380337 | Phase 2 | Nov 30, 2020 | Stanford University |
| NCT04659382 | Phase 2 | Oct 7, 2020 | Federation Francophone de Cancerologie Digestive |
| NCT04522284 | Phase 1/Phase 2 (Phase 2) | Aug 20, 2020 | National University of Singapore |
| NCT04543695 | Phase 2 | Jul 1, 2020 | Chinese Academy of Medical Sciences, Guizhou Medical University, Jilin Provincial Tumor Hospital, Xijing Hospital |
| NCT04416854 | Phase 3 | Apr 1, 2020 | Fudan University |
| NCT04098796 | Phase 2 | Oct 1, 2019 | China Medical University |
| NCT03671252 | Phase 3 | Sep 25, 2018 | Sun Yat-Sen University |
| NCT03666442 | Phase 2 | Jun 1, 2018 | Sichuan University |
| NCT03565029 | Phase 2 | Jun 1, 2018 | University of Milan |
| NCT03484221 | Phase 2 | Apr 1, 2018 | China Medical University |
| NCT03431428 | Phase 3 | Jan 1, 2018 | China Medical University, Chinese Academy of Medical Sciences, Dalian Medical University, Fudan University, Harbin Medical University, Jilin Provincial Tumor Hospital, Jilin University, Shengjing Hospital, Sun Yat-Sen University, The First People's Hospital of Jingzhou |
| NCT03355612 | Phase 3 | Dec 20, 2017 | Tianjin Medical University |
| NCT03322969 | Phase 2 | Aug 23, 2017 | Chinese Academy of Medical Sciences |
Showing 14 of 14 trials
Page 1 / 1
Organizations
Research & Development (18)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 4 | 3 | 2 | 2017 |
| China Medical University | Academic/Hospital | 3 | 2 | 2 | 2018 |
| Fudan University | Academic/Hospital | 2 | 1 | 1 | 2018 |
| Jilin Provincial Tumor Hospital | Academic/Hospital | 2 | 0 | 2 | 2018 |
| Sun Yat-Sen University | Academic/Hospital | 2 | 1 | 1 | 2018 |
| Dalian Medical University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Federation Francophone de Cancerologie Digestive | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Guizhou Medical University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Harbin Medical University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Jilin University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| National University of Singapore | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Shengjing Hospital | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Sichuan University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| The First People's Hospital of Jingzhou | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Tianjin Medical University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| University of Milan | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Xijing Hospital | Academic/Hospital | 1 | 0 | 1 | 2020 |
18 organizations
Page 1 / 1